Clinical Trial Update: A Study of Avastin (Bevacizumab) Plus Herceptin (Trastuzumab) in Patients With Primary Inflammatory HER2-Positive Breast Cancer. [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the combination of Avastin (bevacizumab) and trastuzumab (Herceptin) in patients with primary inflammatory HER2-positive breast cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Breast Cancer

Drugs mentioned

• Avastin (bevacizumab)
• HERCEPTIN (trastuzumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-01-06